selpercatinib (Retsevmo®)
HSE100051
25034a
selpercatinib
Retsevmo®
Eli Lilly
27/06/2025
02/09/2022
Rapid Review Completed
01/07/2025
Pricing and Reimbursement Application Complete
27/06/2025
Rapid Review Commissioned
15/05/2025